A Novel Treatment for Fibromyalgia Improves Clinical Outcomes in a Community-Based Study

REFERENCES

• Felson D T. Epidemiologic research in fibromyalgia. J Rheumatol 16[suppl9] 1989; 7–11
   Google Scholar
• Waylonis G W, Heck W. Fibromyalgia syndrome: New associations. Am J Phys Med Rehab 1992; 71: 343–348
   PubMed Web of Science ®Google Scholar
• Clauw D J. The pathogenesis of chronic pain and fatigue syndromes with special reference to fibromalgia. Med Hypotheses 1995; 44: 369–378
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe H A, Yunus M B, Bennett R M, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990; 33: 160–172
   PubMed Web of Science ®Google Scholar
• Forseth K O, Gran J T. The prevalence of fibromyalgia among women aged 20 to 49 years in Arendal, Norway. Clin Rheumatol 1992; 21: 74–78
   Google Scholar
• Wolfe F, Ross K, Anderson J, Russell I J, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19–28
   PubMed Web of Science ®Google Scholar
• Schochat T, Croft P, Raspe H. The epidemiology of fibromyalgia. Br J Rheumatol 1994; 33: 783–786
   PubMedGoogle Scholar
• Kravitz H M, Katz R, Kot E, Helmke N, Fawcett J. Biochemical clues to a fibromyalgia-depression link: Imipramine binding in patients with fibromyalgia or depression and in healthy controls. J Rheumatol 1992; 19: 1428–1432
   PubMed Web of Science ®Google Scholar
• Russell I J, Vipraio G A, Morgan W W, Bowden C L. Is there a metabolic basis for the fibrositis syndrome?. Am J Med 1986; 81: 50–54, [suppl 3A]
   PubMed Web of Science ®Google Scholar
• Moldofsky H, Warsh J J. Plasma tryptophan and musculoskeletal pain in non-articular rheumatism. Pain 1978; 5: 65–71
   PubMed Web of Science ®Google Scholar
• Russell I J, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992; 35: 550–556
   PubMed Web of Science ®Google Scholar
• Russell I J, Michalek J E, Vipraio G A, Fletcher E M, Javors M A, Bowden C A. Platelet 3H-Imipratnine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1992; 19: 104–109
   PubMed Web of Science ®Google Scholar
• Russell I J. Neurohormonal aspects of fibromyalgia syndrome. Rheum Dis Clin N Am 1989; 15: 149–168
   PubMed Web of Science ®Google Scholar
• Yunus M B. Towards a model of pathophysiology of fibromyalgia: Aberrant central pain mechanisms with peripheral modulation [editorial]. J Rheumatol 1992; 19: 846–850
   PubMed Web of Science ®Google Scholar
• Griep E N, Boersma J W, de Kloet E R. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993; 20: 469–474
   PubMed Web of Science ®Google Scholar
• Crofford L J, Pillemer S R, Kalogeras K T, Cash J M, Michelson D, Kling M A, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994; 37: 1583–1592
   PubMed Web of Science ®Google Scholar
• Moldofsky H, Scarisbrick P, England R, Smythe H M. Musculoskeletal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom Med 1975; 37: 341–351
   PubMed Web of Science ®Google Scholar
• Bengtsson A, Henriksson K G. The muscle in fibromyalgia: a review of Swedish studies. J Rheumatol 1989; 16: 144–149, [suppl 19]
   Google Scholar
• Boissevain M D, McCain G A. Toward an integrated understanding of fibromyalgia syndrome. II. Psychological and phenomenological aspects. Pain 1991; 45: 239–248
   PubMed Web of Science ®Google Scholar
• Powers R. Fibromyalgia: An age-old malady begging for respect. J Gen Int Med 1993; 8: 93–105
   PubMedGoogle Scholar
• Russell I J. Neurohormonal aspects of fibromyalgia syndrome. Rheum Dis Clin N Am 1989; 15: 149–168
   PubMed Web of Science ®Google Scholar
• Caro X J, Ojo-Maize E A, Agoplan M S, Peter J B. Natural killer cell function in primary fibrositis (fibromyalgia) syndrome. Arthritis Rheum 1993; 36(9S)D114
   Google Scholar
• Hader N, Rimon D, Kinarty A, Lahat N. Altered interleukin-2 secretion in patients with primary fibromyalgia syndrome. Arthritis Rheum 1991; 34: 866–872
   PubMed Web of Science ®Google Scholar
• Caro X J. Immunofluorescent detection of IgG at the dermal-epidermal junction in patients with apparent primary fibrositis syndrome. Arthritis Rheum 1984; 27: 1174–1179
   PubMed Web of Science ®Google Scholar
• Simms R W, Felson D T, Goldenberg D L. Development of preliminary criteria for response to treatment in fibromyalgia syndrome. J Rheumatol 1991; 18: 1558–1563
   PubMed Web of Science ®Google Scholar
• Bryan W, Bryan M. Application of an in vitro cytotoxic reaction to clinical diagnosis of food allergy. Laryngoscope 1960; 70: 810–924
   PubMedGoogle Scholar
• Pasula M J. The ALCAT test: in vitro procedure for determining food sensitivities. Folia Med Cracov 1993; 34: 153–157
   PubMedGoogle Scholar
• Jaffe R, Deykin D. Evidence for the structural requirement for the aggregation of platelets by collagen. J Clin Invest 1974; 53: 875–883
   PubMed Web of Science ®Google Scholar
• McCain G A, Bell D A, Mai F M, Halliday P D. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum 1988; 31: 1135–1141
   PubMed Web of Science ®Google Scholar
• Kaplan K H, Goldenberg D L, Galvin-Nadeau M. The impact of a meditation-based stress reduction program on fibromyalgia. Gen Hosp Psychiatry 1993; 15: 284–289
   PubMed Web of Science ®Google Scholar
• Wigers S H, Stiles T C, Vogel P A. Effects of aerobic exercise versus stress management treatment in fibromyalgia: A 4.5 years prospective study. Scand J Rheumatol 1996; 25: 77–86
   PubMed Web of Science ®Google Scholar
• Hawley D J, Wolfe F, Cathey M A. Pain, functional disability, and psychological status: A 12 month study of severity in fibromyalgia. J Rheumatol 1988; 15: 1551–1556
   PubMed Web of Science ®Google Scholar
• Buchwald D, Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 1994; 154: 2049–2053
   PubMed Web of Science ®Google Scholar
• Zeim G. Chronic fatigue, fibromyalgia, and chemical sensitivity: Overlapping disorders. Arch Intern Med 1995; 155: 1913
   PubMedGoogle Scholar